P53 and HER2 neu expression in breast carcinoma occuring in young women

被引：0
|
作者：
Maru, D [1 ]
Middleton, LP [1 ]
Wang, S [1 ]
Valero, V [1 ]
Sahin, A [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
167
引用
收藏
页码：40A / 40A
页数：1
相关论文
共 50 条
  • [21] Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to Her-2/neu and p53 protein expression in invasive ductal carcinoma
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 145 - 145
  • [22] Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma
    Cho, M. H.
    Yoon, J. H.
    Jaegal, Y. J.
    Choi, Y. D.
    Lee, J. S.
    Lee, J. H.
    Nam, J. H.
    Choi, C.
    Lee, M. C.
    Park, C. S.
    Juhng, S. Woo
    Min, K. W.
    BREAST, 2006, 15 (03): : 390 - 398
  • [23] Expression of ER, p53 and HER-2/neu in medullary carcinoma and infiltrating ductal carcinoma with medullary feature
    Kim, S.
    Lee, M.
    Woo, H.
    Han, S.
    Lim, C.
    Sohn, D.
    Kim, E.
    BREAST, 2009, 18 : S30 - S30
  • [24] Estrogen and progesterone receptor status, p53 and Her-2/neu protein expression in metachronous bilateral breast carcinoma (MBBC)
    Vrcel, V
    Brogi, E
    Cranor, ML
    Son, T
    Hudis, C
    Norton, L
    Tan, LK
    LABORATORY INVESTIGATION, 2002, 82 (01) : 55A - 55A
  • [25] Estrogen and progesterone receptor status, p53 and Her-2/neu protein expression in metachronous bilateral breast carcinoma (MBBC)
    Vrcel, V
    Brogi, E
    Cranor, ML
    Son, T
    Hudis, C
    Norton, L
    Tan, LK
    MODERN PATHOLOGY, 2002, 15 (01) : 55A - 55A
  • [26] LOSS OF HETEROZYGOSITY ON CHROMOSOME 16Q, EXPRESSION OF HER2/NEU AND P53 MUTATIONS IN ENDOMETRIAL CANCER
    MASSENKEIL, G
    CADUFF, R
    OBERHUBER, H
    SCHWARTEWALDHOFF, I
    DIENER, PA
    BANNWART, F
    WALT, H
    SCHAFER, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (01) : 157 - 162
  • [27] Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma
    Matsuo K.
    Fukutomi T.
    Akashi-Tanaka S.
    Hasegawa T.
    Tsuda H.
    Breast Cancer, 2002, 9 (2) : 127 - 133
  • [28] Differences in estrogen receptor status, HER2, and p53 comparing metachronous bilateral breast carcinoma
    Matsuo, K
    Fukutomi, T
    Tsuda, H
    Akashi-Tanaka, S
    Shimizu, C
    Hasegawa, T
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 77 (01) : 31 - 34
  • [29] Expression of vascular endothelial growth factor in invasive ductal carcinoma of the breast and the relation to angiogenesis and p53 and HER-2/neu protein expression
    Lee, JS
    Kim, HS
    Jung, JJ
    Kim, YB
    Lee, MC
    Park, CS
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (04): : 289 - 295
  • [30] The molecular epidemiology of breast cancer: HER-2/neu and p53 overexpression among women with breast cancer.
    Bernstein, JL
    Press, M
    Thompson, WD
    Lapinski, R
    Bleiweiss, I
    Zhou, JY
    Schildkraut, J
    Gammon, M
    Haile, R
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (11) : S9 - S9
12345